J&J to record $700 million charge related to abandoned drug program

98

Johnson & Johnson on Thursday said it will record a nearly $700 million impairment charge in the first quarter of 2019 related to the abandoned development of its experimental antiviral drug, AL-8176.

http://feeds.reuters.com/~r/reuters/healthNews/~3/yX7LZN9mDEk/jj-to-record-700-million-charge-related-to-abandoned-drug-program-idUSKCN1R22LF